Roles of p53 and MDM2 in tumor proliferation and determination of the prognosis of transitional cell carcinoma of the renal pelvis and ureter

International Journal of Urology - Tập 7 Số 12 - Trang 457-463 - 2000
Hiroshi Hashimoto1, Yoichi Sue1, Yuji Saga1, Masayuki Tokumitsu1, Sunao Yachiku1
1Department of Urology, Asahikawa Medical College, Asahikawa, Japan

Tóm tắt

Abstract Background The significance of p53 overexpression for the prognosis of transitional cell carcinoma (TCC) of the renal pelvis and ureter remains controversial. Simultaneous evaluation of p53 and MDM2 may enable better prediction of tumor proliferation and patient prognosis than that obtained with evaluation of p53 alone.Methods Immunohistochemical detection of p53 protein, MDM2 protein and Ki‐67 antigen as proliferation markers was performed for tissue samples obtained from 74 patients with TCC of the renal pelvis and ureter. The correlations of p53/MDM2 overexpression with conventional pathological features, Ki‐67 labelling index (LI) and patient survival were studied.Results Overexpression of p53 was related to progression of each of the pathological features examined (grade, stage, type of infiltration, vascular invasion and lymphatic invasion) and Ki‐67 LI was significantly higher with high p53 expression than with low p53 expression. However, overexpression of MDM2 was related to neither disease progression nor Ki‐67 LI. Survival analyses were performed for 66 patients. Univariate analysis showed p53 to be a useful prognostic indicator, but in a multivariate analysis only type of infiltration and Ki‐67 LI were independent survival markers, while p53 was not. Overexpression of MDM2 was unrelated to patient survival, and the combination of p53 and MDM2 for survival indication was found not to be useful.Conclusions Overexpression of p53 is related to disease progression, increased tumor proliferation and patient survival for TCC of the renal pelvis and ureter, but the independent prognostic value of p53 did not reach statistical significance. Combined analysis of MDM2 with p53 cannot be recommended for examination of the malignant potential of TCC of the renal pelvis and ureter.

Từ khóa


Tài liệu tham khảo

10.1046/j.1464-410X.1996.00085.x

Marks JR, 1991, Overexpression and mutation of p53 in epithelial ovarian cancer., Cancer Res, 51, 2979

10.1093/jnci/85.1.53

10.1002/ijc.2910530304

10.1111/j.1442-2042.1994.tb00007.x

10.1016/S0022-5347(01)67517-7

10.1016/S0022-5347(01)66855-1

10.1016/S0046-8177(96)90347-0

10.1002/(sici)1096-9896(199602)178:2<133::aid-path455>3.0.co;2-f

10.1002/(sici)1097-0142(19970601)79:11<2178::aid-cncr16>3.0.co;2-t

10.1038/bjc.1998.127

10.1159/000030239

10.1002/(sici)1097-0215(19981023)79:5<531::aid-ijc15>3.0.co;2-4

10.1002/j.1460-2075.1991.tb07676.x

10.1093/jnci/86.17.1331

Schmitz‐Drager BJ, 1997, p53 and MDM2 in the development and progression of bladder cancer., Eur. Urol., 32, 487, 10.1159/000480813

10.1016/S0344-0338(97)80055-6

10.1159/000011971

10.1136/jcp.46.12.1080

Japanese Urological Association, 1990, General Rules for Clinical and Pathological Studies on Renal Pelvic and Ureteral Cancer

10.1002/(sici)1097-0142(19960815)78:4<827::aid-cncr20>3.0.co;2-w

10.1016/S0022-5347(01)66036-1

10.1038/nm0896-912

Thông tin
Thông tin xuất bản

International Journal of Urology

Tập 7 Số 12

457-463

Thông tin tác giả